Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-089938
Filing Date
2025-06-25
Accepted
2025-06-25 16:00:04
Documents
2
Period of Report
2025-06-23

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1632
2 EX-24.1 nktx-ex24_1.htm EX-24.1 20137
  Complete submission text file 0000950170-25-089938.txt   23166
Mailing Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1150 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080 (925) 407-1049
Nkarta, Inc. (Issuer) CIK: 0001787400 (see all company filings)

EIN.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 52 CAMBRIDGE WAY PRINCETON JUNCTION NJ 08550
Business Address
Rose Shawn Marshall (Reporting) CIK: 0002073530 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39370 | Film No.: 251073575